Crinetics Pharmaceuticals, Inc. (CRNX)
84.85
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
84.85
0.00 (0.00%)
After-Hours: 18:22
Crinetics Pharmaceuticals Total Return Level : 84.85 for Aug. 27, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 27, 2026 | 84.85 |
| August 26, 2026 | 84.84 |
| August 25, 2026 | 84.86 |
| August 24, 2026 | 84.78 |
| August 21, 2026 | 84.69 |
| August 20, 2026 | 84.69 |
| August 19, 2026 | 84.69 |
| August 18, 2026 | 84.72 |
| August 17, 2026 | 84.75 |
| August 14, 2026 | 84.70 |
| August 13, 2026 | 84.44 |
| August 12, 2026 | 84.46 |
| August 11, 2026 | 84.36 |
| August 10, 2026 | 84.15 |
| August 07, 2026 | 84.08 |
| August 06, 2026 | 83.92 |
| August 05, 2026 | 84.00 |
| August 04, 2026 | 83.86 |
| August 03, 2026 | 83.76 |
| July 31, 2026 | 83.52 |
| July 30, 2026 | 83.63 |
| July 29, 2026 | 83.88 |
| July 28, 2026 | 83.86 |
| July 27, 2026 | 83.85 |
| July 24, 2026 | 83.73 |
| Date | Value |
|---|---|
| July 23, 2026 | 83.65 |
| July 22, 2026 | 83.72 |
| July 21, 2026 | 83.90 |
| July 20, 2026 | 83.87 |
| July 17, 2026 | 83.86 |
| July 16, 2026 | 83.91 |
| July 15, 2026 | 83.90 |
| July 14, 2026 | 83.71 |
| July 13, 2026 | 83.67 |
| July 10, 2026 | 83.58 |
| July 09, 2026 | 83.62 |
| July 08, 2026 | 83.49 |
| July 07, 2026 | 83.53 |
| July 06, 2026 | 42.03 |
| July 02, 2026 | 42.23 |
| July 01, 2026 | 38.68 |
| June 30, 2026 | 37.42 |
| June 29, 2026 | 36.94 |
| June 26, 2026 | 36.70 |
| June 25, 2026 | 34.99 |
| June 24, 2026 | 36.18 |
| June 23, 2026 | 35.91 |
| June 22, 2026 | 35.38 |
| June 18, 2026 | 35.87 |
| June 17, 2026 | 35.75 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 547.55 |
| Johnson & Johnson | 634.18 |
| Eli Lilly & Co. | 3107.50 |
| Pfizer Inc. | 93.73 |
| Bristol Myers Squibb Co. | 253.30 |